Who
Stephen P. Robertson
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Aurinia Pharmaceuticals.
In numbers
- Trades disclosed
- 32
- Buys
- 1
- Sells
- 7
- Bought
- $15K
- Sold
- $2.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Jan 2021
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $190K11,939 at $15.95 | filing |
| 10 Sep 2026filed 11 Sep 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $190K11,939 at $15.95 | filing |
| 21 Aug 2026filed 25 Aug 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $356K20,975 at $16.97 | filing |
| 21 Aug 2026filed 25 Aug 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $356K20,975 at $16.97 | filing |
| 18 May 2026filed 20 May 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —115,541 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —115,541 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $519K36,525 at $14.21 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $519K36,525 at $14.21 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —59,090 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,813 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,813 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —59,090 at $0.00 | filing |
| 20 Feb 2026filed 23 Feb 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $499K34,638 at $14.40 | filing |
| 20 Feb 2026filed 23 Feb 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $499K34,638 at $14.40 | filing |
| 2 Jan 2026filed 5 Jan 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —48,558 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $644K40,385 at $15.95 | filing |
| 2 Jan 2026filed 5 Jan 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —48,558 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $644K40,385 at $15.95 | filing |
| 4 Mar 2025filed 4 Mar 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $456K57,607 at $7.92 | filing |
| 3 Mar 2025filed 4 Mar 2025 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —102,406 at $0.00 | filing |
News
Aurinia Pharmaceuticals (NASDAQ:AUPH) and Shattuck Labs (NASDAQ:STTK) Financial ContrastAUPH · themarketsdaily.com · 24 Oct 2026Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Cross Above Fifty Day Moving Average – Time to Sell?AUPH · tickerreport.com · 17 Oct 2026
0 headlines in the last 90 days name Stephen P. Robertson; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.